Media Release from Civil Society Singapore

Singapore, 14 October 2013 – The mother of a 20 year old prison inmate, who died in custody in circumstances widely thought “controversial”, will go to court here Wednesday. Madam Selvi Narayanasamy has petitioned for a reopening of the Coroner’s Inquiry discontinued after criminal proceedings in July.

Dinesh Raman, who was due for release in December 2010, died of positional asphyxiation three months earlier, following what the Prison Service claimed was an unprovoked attack on a prison officer.

The slight, 51kg 20 year old was subdued with pepper spray and overpowered by eight officers. He was left unresponsive in a prone position in an isolation cell. The Prison Service admitted it did nothing beyond splash water in his face. Shortly before lunch on the same day, he was pronounced dead at a local hospital. Cause of death was recorded as “cardio pulmonary failure, pending investigation”.

Photographs of the deceased released with the family’s permission showed extensive bruising to the face and body.

The Home Ministry conducted an internal Committee of Inquiry and disciplinary proceedings against the eight officers. Neither report was made public.

Subsequent government statements and media reports contained contradictory accounts of the death.

One prison officer was convicted of negligence and fined S$10,000. The Home Ministry claims the other seven have been redeployed to non-operational duties.

Following the criminal proceedings, the State Coroner decided to abandon his inquest. Rachel Zeng, a spokesperson for the Justice For Dinesh Campaign, noted, “The death clearly meets the legal criteria for a mandatory inquiry. The Coroner should not have abandoned the inquest.”

Government officials met with the family on numerous occasions to attempt to convince them to give up their desire for an inquest. A government press release in August claims the mother sought “windfall damages”. Madam Selvi strongly denies this: “I want to know what happened to my son,” she said.

In June, Madam Selvi petitioned the Attorney General to reopen the inquest on the grounds that with a guilty plea entered in the criminal proceedings, the cause and circumstances of Dinesh’s death were never established. She was turned down.

Madam Selvi has now applied to the High Court for a Mandatory Order to compel the Coroner to reopen his inquiry.

A widespread campaign to call on the Singapore government to reopen the inquiry has gathered steam with prominent independent bloggers and news sites expressing concerns about the death.

Maruah, the city state’s human rights watchdog, together with prominent civil activists and writers, have supported the demand for an inquest.

 

A detailed timeline dossier of the case (with photos) is available here

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

European Union calls on Singapore authorities to halt execution of Muhammad Ridzuan

The European Union Delegation to Singapore has just issued the following statement…

泰王:违宪反传统 公主角逐首相职或受阻

泰国国王哇集拉隆功(Maha Vajiralongkorn)指乌汶叻公主(Princess Ubolratana)参选首相之举“不恰当”且违宪、违反皇室传统。 在泰公主於2月8日早上宣布竞选首相职位后,泰王发出皇室声明,指公主的候选资格违反了宪法和皇室传统,所有皇室成员都不适合参政。 根据彭博新闻网指出,泰国国王表示, “泰国君主制是将凝聚民心的中心点。君王和皇室成员地位应该超越政治。” 这显示了高级皇室成员之间存在着前所未有的分歧,或加剧东南亚第二大经济体的政治紧张局势。 泰爱国党暂不做回应 对此,泰国爱国党表示暂时不作回应。 身为影星的乌汶叻公主,在其拥有10万追随者的社媒Instagram帐号感谢泰国人民的支持,“我很高兴有机会为国家带来光荣。”她日前也在该账号指出已放弃了王室头衔,会像平民一样生活。“我接受泰爱国党提名我竞选首相,以显示在宪法下我的权利和自由并没有任何特权是高于其他泰国公民的。” 67岁的乌汶叻公主是泰王哇集拉隆功的大姐。早前她宣布将代表泰爱国党,和泰国现任首相巴育在来临的泰国大选一较高低。 带给巴育助力…

Singapore-based photographer Juliana Tan launches her first travel zine

In 2015, Singapore-based photographer Juliana Tan swapped her comfortable life here for…

致癌物NMBA含量超标 卫生局回收三种氯沙坦药物

卫生科学局(HSA)宣布召回三款含氯沙坦(losartan)的治高血压药物:Hyperten、Losagen和Losartas,理由是这些药物中,含有超过国际标准的亚硝酸胺(NMBA)致癌污染物质。 根据卫生部今日(28日)发出的文告,这三款氯沙坦药物,是由印度药厂Hetero Labs制造,其中的致癌物质超出国际可接受的标准。 卫生部估计有13万7000名病患,目前正在使用这三款氯沙坦药物。其中有13万病患是从公共医疗机构获取Losartas牌的治高血压药。 建议勿马上停药,短期内服用不构威胁 不过,卫生科学局不建议病患马上停止服用有关药物,避免影响健康。再者,这些药物短期内不会构成健康威胁。“我们已建议医疗人员,为病患检讨和提供病患其他替代建议。” 病患若不确定自己是否受影响,宜咨询医生以提供建议。 卫生部也指出,那些来临看诊预约在今年7月1日之前的病患,应继续按照原定日期前去看病,并跟医生讨论替代药物方案;至于预约在7月1日或之后的病患,会收到通知请他们提早看病或讨论替代用药方案。 该局也指出,不是所有氯沙坦药物都被召回,我国引进的10款款氯沙坦药物中,只有上述三款含有超过我国容许标准的亚硝酸胺容量。其余七款经化验未发现亚硝酸胺。 公共医疗机构也将增加引进其他未受影响品牌的氯沙坦药物。至于那些正服用氯沙坦药物的病患,在这段期间转换治疗方案时不需支付更多费用,替代药物价格可能相同或更低。至于进行额外诊断和评估也获免除。 而病患退还上述受影响品牌的氯沙坦药物,也将获得退款。 全球高血压药回收风波…